Keynote & Special Events
Keynotes Address
Tuesday, March 17
11:30am - 12:45pm
Location: Special Events Hall
The Future of Pharmaceutical and Biopharmaceutical Manufacturing
Open to all badge holders
G. Steven Burrill will kick off this session by presenting his vision of the future of healthcare and the overriding trends affecting the global industry. His presentation will be followed by a panel discussion with senior executives from manufacturing organizations at Big Pharma and Big Biotech companies about how they are handling the major concerns affecting their organizations and what they envision for the future of pharmaceutical manufacturing.
Panelists will include:
- G. Steven Burrill, Chief Executive Officer, Burrill & Company
Tim Moore, Senior Vice President, Global Supply Chain, Genentech
Divakar Ramakrishnan, PhD, Executive Director, Manufacturing Science and Technology,
Eli Lilly & Co
Michael D. Kowolenko, PhD, Senior Vice President, Biotech Operating Unit, Technical
Operations and Product Supply, Wyeth Pharmaceuticals
Moderator: Laura Bush, Editor in Chief, BioPharm International magazine
Learn more about what you can expect to hear from these leading industry experts. Listen to these podcasts interviews with our keynote speakers.
Opening Night Reception
Tuesday, March 17
5:00pm - 6:30pm
Location: Special Events Hall
Come celebrate St. Patrick's Day and network with industry peers
Open to all badge holders
Sponsored by: 
Featured Session
Wednesday, March 18
9:00am - 10:00am
The Current State of International Outsourcing
Open to all badge holders
Presented by: Jim Miller, President, PharmSource
With an imperative to reduce costs and open new markets for growth, pharmaceutical companies have been turning to companies in emerging markets for a broader array of services. However, sourcing in emerging markets is fraught with risks and obstacles. This program will address the current state of outsourcing to emerging markets and identify the key trends that will shape sourcing practices in coming years.
Sponsored by: 
Special Conference Lunch Presentation
Wednesday, March 18, 12:00pm – 1:30pm
Location: Room 1E19/20
Single-Use Strategies in Bioprocessing: Reducing Cost, Time and Risk
Separate Registration Required. Luncheon is included in select Conference packages or may be purchased separately in advance. Please call Diana Press at 800-363-3631 for assistance. Seating is limited.
Single-use technologies have been transforming the landscape of industrial bioprocessing. Approaches to assessing advantages and disadvantages to their adoption include sophisticated cost-modeling programs and development of recommended guidelines by a number of industry groups and associations. Case studies are beginning to make their way into the literature as companies explore the practicalities of their use. Still to be discussed, however, are the longer-term implications of single-use components and technologies on the future of bioprocessing: Is their use a cost-saving strategy overall? To what extent will economic factors drive their increased adoption? How are environmental considerations for their disposal – and those related costs – affecting the rate of their acceptance? What economies of scale do and do not contribute to their acceptance? A panel comprising suppliers, end-users, and association representatives will discuss economic strategies that reduce the cost, time, and risk of bioprocessing using single-use technologies.
Moderator: S. Anne Montgomery, Editor in Chief, BioProcess International
Chair: Jerold Martin, Sr. Vice President, Global Scientific Affairs, Pall Corp.
Panelists
- Gerard Gach, Director of Marketing, ReadyToProcess Program, GE Healthcare
- James Robinson, VP Technical and Quality Operations, Novavax
- Lisa Crossley, PhD, PEng, President and CEO, Natrix Separations
- Miriam Monge, Vice President of Marketing and Disposables Systems Implementation, BioPharm Services
- Rick Stock, PhD, associate consultant, Bioprocess Technology Consultants
Presented by: 
Facility-of-the-Year Innovation Area
Learn about award-winning pharmaceutical and biopharmaceutical manufacturing facilities featuring the latest innovations and cutting edge technologies. FOYA is the premier global awards program focused on recognizing the innovations and technologies utilized by manufacturing facilities serving the regulated health care industry.